The Academy of Medical Sciences has suggested that personalised medicines may offer a range of opportunities to prevent, instead of merely treat, disease.
Brimelow, A. (2015). New medicines ‘should prevent not just treat disease’. London: BBC Health News, December 5th 2015.
NHS England’s Personalised Medicine Strategy
Sir Bruce Keogh outlined NHS England’s strategy for personalised medicine.
Personalised Medicine Strategy – Sir Bruce Keogh, National Medical Director. London: NHS England, September 18th 2015.
A possible breakthrough in the early treatment of multiple types of cancers by targeting “trunk mutations” using the patient’s immune system?
Gallagher, J. (2016). Scientists ‘find cancer’s Achilles heel’. London: BBC Health News, March 4th 2016.
Mutational Signatures Behind Breast Cancer
Researchers at the Sanger Institute in Cambridge have announced a historic achievement in understanding of the genetic changes (“mutational signatures”) causing twelve different types of breast cancer. The mutated genes and their proteins are potential targets for new tailored therapeutics:
Gallagher, J. (2016). Breast cancer: scientists hail ‘milestone’ genetic find. London: BBC Health News, May 1st 2016.
Annual Meeting of the American Society of Clinical Oncology (Chicago 2016)
Cancer is said to be entering a new era of personalised “precision medicine”, with many trials underway to evaluate drugs which target the specific weaknesses in each patient’s tumour. Cancer Research UK, on the other hand, believes that too few UK patients are being tested and assessed (currently) for suitability to receive precision treatments.
Gallagher, J. (2016). ‘New era’ of personalised cancer drugs, say doctors. London: BBC Health News, June 4th 2016.
Possibly of interest is the prospect of drug developed using artificial intelligence:
Gallagher, J. (2016). Artificial Intelligence ‘outsmarts cancer’. London: BBC Health News, June 8th 2016.
Professor Sue Hill OBE, Chief Scientific Officer for England, and the NHS England senior responsible officer for Genomics, leads development of the NHS England Personalised Medicine Strategy.
“The Five Year Forward View and the NHS Constitution recognise the NHS will continue to flourish if it works at the limits of science”.
Te following piece touches upon the Personalised Medicine Zone at the Health and Care Innovation Expo (2016), the 100,000 Genomes Project and Health Education England (HEE)’s Genomics Education Programme:
Innovation is creating the wonder of personalised medicine – Professor Sue Hill. [Online]: NHS England, August 25th 2016.